USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 12, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 12, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 13, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 9, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 9, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 9, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 9, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 14, 2017 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Jan 14, 2017 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Jan 10, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 15, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 15, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 26, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 11, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 30, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 16, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 15, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 15, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 15, 2016 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 15, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 10, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 4, 2016 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED | Loading... |
| Jun 3, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 30, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Contrasting agent for ultrasound diagnostic imaging; cells for medical or clinical use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for inhalation therapy; and vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
PHARMACY PEG
Classification
International Classes
005